Services
Infogene also offers, on an outsourcing basis, the service RT-PCR for the detection of the new coronavirus SARS-CoV-2 - infoCOVID-19, the most complete service for the detection and typing of the Human Papillomavirus (HPV) on the market - infotipoHPV and the service for the detection of infectious agents of the genital tract by PCR - infoDSTs.
infoCOVID-19
The infoCOVID-19 service involves the detection of SARS-CoV-2 RNA using real-time PCR technology. The presence of SARS-CoV-2 is tested using real-time PCR (Polymerase Chain Reaction) technology for the amplification of the E gene of the said infectious agent, and confirmatory analysis is carried out for the specific amplification of the RdRp, N and/or genes ORF1ab. At the same time, the cell samples are tested for the quality of the biological material by specific amplification of human ribonuclease P using real-time PCR. After analysis and validation of the results by the Technical Director, the analysis reports are sent digitally to the respective laboratories of origin of the samples within 24 hours (working days) after receipt of the samples.
infotipoHPV
The infotipoHPV service is available in 3 modes: “ALTO RISCO (AR)”, “ALTO RISCO PLUS” and “COMPLETE”.
- infotipoHPV AR: Detection service and individualized genotyping of all types of HIGH-RISK HPVs frequently associated with the development of high-grade lesions and carcinomas (HPVs 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68).
- infotipoHPV AR Plus: Individualized detection and genotyping service for all types of HIGH-RISK HPV (HPVs 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68) and 4 "possible high risk HPV" genotypes (HPVs 26, 53, 73 and 82), complemented by detection of other HPV types.
- infotipoHPV Complete: Complete and individual detection service for all types of HPV in any biological sample.
Results are delivered in an average of 3 to 7 business days, depending on the type of test. In the infotipoHPV Complete service, the method used allows detection and genotyping of all mucosotropic HPV genotypes (i.e., high oncogenic risk, intermediate-risk, low-risk, and unknown-risk viruses), detection in specimens from males, and detection in paraffin-embedded histologic specimens.
infoDSTs
The infoDSTs service enables the detection of infectious agents of the urogenital tract by PCR, detecting up to 8 pathogens in cytological specimens, swabs and urine within a maximum of 5 working days.
- Herpes simplex virus type 1 (HSV-1)
- Herpes simplex virus type 2 (HSV-2)
- Chlamydia trachomatis (CT)
- Neisseria gonorrhoeae (NG)
- Mycoplasma hominis (MH)
- Mycoplasma genitalium (MG)
- Treponema pallidum (TP)
- Trichomonas vaginalis (TV)
- Ureaplasma urealyticum (UU)
- Ureaplasma parvum (UP)
Panels:
- Screening for 1 STI
- Screening for 2 STIs
- Screening for 3 STIs:
A – CT, NG, MGB – HSV-1, HSV-2, TP - Screening for 7 STIs (CT, NG, MG, MH, UP, UU, TV)
- Screening for 10 STIs (CT, NG, MG, MH, UP, UU, TV, HSV-1, HSV-2, TP)




